1. Home
  2. KOSS vs NKGN Comparison

KOSS vs NKGN Comparison

Compare KOSS & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOSS
  • NKGN
  • Stock Information
  • Founded
  • KOSS 1953
  • NKGN 2017
  • Country
  • KOSS United States
  • NKGN United States
  • Employees
  • KOSS N/A
  • NKGN N/A
  • Industry
  • KOSS Consumer Electronics/Appliances
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KOSS Consumer Staples
  • NKGN Health Care
  • Exchange
  • KOSS Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • KOSS 81.3M
  • NKGN 35.3M
  • IPO Year
  • KOSS N/A
  • NKGN N/A
  • Fundamental
  • Price
  • KOSS $10.18
  • NKGN $0.90
  • Analyst Decision
  • KOSS
  • NKGN
  • Analyst Count
  • KOSS 0
  • NKGN 0
  • Target Price
  • KOSS N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • KOSS 8.7M
  • NKGN 112.8K
  • Earning Date
  • KOSS 08-22-2024
  • NKGN 08-16-2024
  • Dividend Yield
  • KOSS N/A
  • NKGN N/A
  • EPS Growth
  • KOSS N/A
  • NKGN N/A
  • EPS
  • KOSS N/A
  • NKGN N/A
  • Revenue
  • KOSS $12,475,699.00
  • NKGN N/A
  • Revenue This Year
  • KOSS N/A
  • NKGN N/A
  • Revenue Next Year
  • KOSS N/A
  • NKGN N/A
  • P/E Ratio
  • KOSS N/A
  • NKGN N/A
  • Revenue Growth
  • KOSS N/A
  • NKGN N/A
  • 52 Week Low
  • KOSS $2.27
  • NKGN $0.78
  • 52 Week High
  • KOSS $18.73
  • NKGN $6.70
  • Technical
  • Relative Strength Index (RSI)
  • KOSS 64.37
  • NKGN 30.38
  • Support Level
  • KOSS $8.51
  • NKGN $0.87
  • Resistance Level
  • KOSS $10.04
  • NKGN $1.37
  • Average True Range (ATR)
  • KOSS 2.48
  • NKGN 0.11
  • MACD
  • KOSS 0.24
  • NKGN -0.03
  • Stochastic Oscillator
  • KOSS 41.96
  • NKGN 5.39

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: